Suppr超能文献

单个中心研究 ProGlide 用于腹主动脉瘤 EVAR 后大口径穿刺孔的闭合。

A Single Center Study of ProGlide Used for Closure of Large-Bore Puncture Holes After EVAR for AAA.

机构信息

Department of Vascular Surgery, Innlandet Hospital Trust, Hamar, Norway.

Department of Cardiothoracic and Vascular Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

出版信息

Vasc Endovascular Surg. 2021 Nov;55(8):798-803. doi: 10.1177/15385744211022654. Epub 2021 Jun 9.

Abstract

PURPOSE

The objective of this study was to evaluate the primary and assisted secondary percutaneous and non-invasive technical success of the ProGlide device on all-comers in a consecutive case series of percutaneous endovascular aortic aneurysm repair (P-EVAR).

METHOD

A single-center consecutive case series where 434 elective and acute P-EVAR procedures were registered prospectively between May 2011 and July 2017. The mean age was 74.5 years ± SD 11.4 years. 82.3% of the patients were male. All patients were pre-planned from CT angiography. Percutaneous access punctures, performed in local anesthesia in the common femoral artery, with a final introducer size between 12-22 Fr OD were included and stratified in 2 groups, 12-16 Fr and 17-22 Fr.

RESULTS

By screening 868 access groins 22 groins were excluded. Of the remaining 846 groins, intended to be treated with ProGlide, 9 groins were excluded peri-procedurally and treated with the Fascia Suture Technique or surgical cutdown. The remaining 837 groins had access closure with ProGlide, with a mean value of 2.15 devices per groin with a slight significant difference between the 2 stratification groups. Primary ProGlide technical success was achieved in 68.1% of the groins. Secondary percutaneous or non-invasive technical success was achieved in 96.9%. Here there was no statistically significant difference between the 2 stratification groups. Thirty-one (3.7%) groin complications were registered during 30-day follow-up and 17 required additional treatment. Total mortality was 2.8%. None of these deaths were related to the access site.

CONCLUSION

ProGlide by itself has a significant failure rate in the closure of large-bore access holes on an unselected cohort of patients eligible for P-EVAR. However, together with adjunct percutaneous or non-invasive methods a success rate of 97% can be achieved. The access complication rate was lower than 4% at 30-day follow-up.

摘要

目的

本研究旨在评估 ProGlide 装置在所有入组患者中行经皮血管内主动脉瘤修复术(P-EVAR)时的主要和辅助二级经皮和非侵入性技术成功率。

方法

这是一项单中心连续病例系列研究,2011 年 5 月至 2017 年 7 月期间前瞻性登记了 434 例择期和急性 P-EVAR 手术。平均年龄为 74.5 岁±11.4 岁。82.3%的患者为男性。所有患者均行 CT 血管造影预计划。本研究纳入并分层了经皮股动脉局部麻醉下穿刺的股动脉穿刺,最终引入器大小为 12-22 Fr OD,穿刺点为 12-16 Fr 和 17-22 Fr 两组。

结果

经筛选 868 个股动脉穿刺点,排除 22 个股动脉穿刺点。在其余 846 个拟用 ProGlide 治疗的股动脉穿刺点中,有 9 个股动脉穿刺点在围手术期被排除,采用筋膜缝合技术或外科切开术进行治疗。其余 837 个股动脉穿刺点使用 ProGlide 进行股动脉穿刺点闭合,每个股动脉穿刺点平均使用 2.15 个装置,两组间有轻微显著差异。主要 ProGlide 技术成功率为 68.1%。次要经皮或非侵入性技术成功率为 96.9%。两组间无统计学差异。31 例(3.7%)股动脉穿刺点并发症在 30 天随访中发现,其中 17 例需要进一步治疗。总死亡率为 2.8%。这些死亡病例均与穿刺点无关。

结论

在未经选择的适合行 P-EVAR 的患者队列中,ProGlide 本身在闭合大口径股动脉穿刺点方面失败率较高。然而,联合经皮或非侵入性方法,成功率可达 97%。30 天随访时股动脉穿刺点并发症发生率低于 4%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验